Replies to post #330731 on Innovation Pharmaceuticals Inc (IPIX)

[bradfordbros]

First the GMU pre-print and next the FDA and human trials. Only then will the investing world re-look at Ipix as everybody knows how desperately a therapeutic is needed for the Covid-19 pandemic. Making the trials official starts us off.

[TheDane]

It hasn’t been tested in a human trial against a virus yet. So “may be” is the best they can do right now.

[petemantx]

Drug creators never speak in absolutes, a lesson they learn very early on in their career training. Never over until the fat lady sings!



OT:Just finished watching the latest stage of the Vuelta de Espana - that is cycling's Tour of Spain. It is one of the big 3 tours which include France, Italy, and Spain.

These cyclists are athletes beyond belief. Going uphill to 13--20% grades (and doing this for MILES) while the overall stage length can go 100 -150 Km. Mind boggling.

Too bad this sport doesn't get more coverage and respect here in the States as the strategy (both individual and team) is as interesting as the race.

The last stage of the tour is tomorrow (starts about 7-8am USA time) and will be a tortuous mountain finish. Give it a look if you stream TV - I have Hulu and it is on the Olympic Channel there.

[farrell90]

Brilacidin is the only anti viral with 3 possible mechanisms of action. All 3 of these are discussed in the pre print article.

The researchers at the George Mason RBL are experienced virologists. They have expressed the opinion that Brilacidin's unique antiviral abilities may be effective against a number of viral diseases. I expect Brilacidin will be studied as they have outlined since many of these diseases have no treatment.

Dr DeGrado is a world expert in protein studies and defensin mimetic pharmacology. My opinion is he would not take time from his extremely successful and busy academic career and his own company to become the scientific advisor at IPIX unless he felt it could be equally successful.

GLTA, Farrell